Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.99 USD | +1.32% | +5.38% | -16.05% |
Chart calendar Astellas Pharma Inc.
Upcoming events on Astellas Pharma Inc.
Past events on Astellas Pharma Inc.
2024-04-25 04:00 am | Q4 2023 Earnings Call |
2024-04-25 02:00 am | Q4 2023 Earnings Release |
2024-03-28 | Investor Meeting |
2024-03-27 | Final dividend |
2024-02-20 08:00 pm | Analyst Meeting - ESG |
2024-02-05 02:00 am | Q3 2023 Earnings Call |
2024-02-05 01:00 am | Q3 2023 Earnings Release |
2023-11-29 | European Society of Gynecology Congress - Abstract #12497 |
2023-11-05 05:30 pm | American Academy Of Ophthalmology Meeting |
2023-11-01 03:00 am | Q2 2023 Earnings Call |
2023-11-01 02:00 am | Q2 2023 Earnings Release |
2023-10-21 | European Society for Medical Oncology Congress |
2023-10-10 | Cell & Gene Meeting on the Mesa Conference |
2023-09-28 06:15 pm | The Menopause Society Meeting |
2023-09-28 05:30 pm | The Menopause Society Meeting |
2023-09-28 04:45 pm | The Menopause Society Meeting |
2023-09-27 | Ex-dividend day for dividende intermédiaire |
2023-08-01 03:00 am | Q1 2023 Earnings Call |
2023-08-01 02:00 am | Q1 2023 Earnings Release |
2023-06-21 09:00 pm | Annual General Meeting |
Past dividends on Astellas Pharma Inc.
2024-03-27 | Final Payment 35 JPY |
2023-09-27 | Interim Payment 35 JPY |
2023-03-29 | Final Payment 30 JPY |
2022-09-28 | Interim Payment 30 JPY |
2022-03-29 | Final Payment 25 JPY |
2021-09-28 | Interim Payment 25 JPY |
2021-03-29 | Final Payment 21 JPY |
2020-09-28 | Interim Payment 21 JPY |
2020-03-29 | Final Payment 20 JPY |
2019-09-26 | Interim Payment 20 JPY |
Annual results
Fiscal Period | March | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million JPY | Released Forecast Spread | 1 306 348 1 300 930 0.42% | 1 300 843 1 274 827 2.04% | 1 249 528 1 258 841 -0.74% | 1 296 163 1 320 041 -1.81% | 1 518 619 1 508 697 0.66% | 1 603 672 1 571 972 2.02% |
EBITDA Million JPY | Released Forecast Spread | 307 370 320 763 -4.18% | 310 387 316 993 -2.08% | 208 703 300 597 -30.57% | 235 370 316 919 -25.73% | 238 767 321 316 -25.69% | 183 358 264 920 -30.79% |
EBIT Million JPY | Released Forecast Spread | 243 912 261 093 -6.58% | 243 991 257 148 -5.12% | 136 051 221 342 -38.53% | 155 686 219 051 -28.93% | 133 029 183 181 -27.38% | 25 518 89 542 -71.5% |
Earnings before Tax (EBT) Million JPY | Released Forecast Spread | 248 967 259 605 -4.1% | 245 350 262 926 -6.68% | 145 324 219 749 -33.87% | 156 886 214 703 -26.93% | 132 361 187 029 -29.23% | 24 969 24 853 0.47% |
Net income Million JPY | Released Forecast Spread | 222 265 215 115 3.32% | 195 411 203 519 -3.98% | 120 589 176 431 -31.65% | 124 086 177 294 -30.01% | 98 714 144 398 -31.64% | 17 045 13 409 27.12% |
EPS JPY | Released Forecast Spread | 115 113 1.61% | 104 113 -7.83% | 64,9 96,5 -32.74% | 67,1 94,2 -28.76% | 54,2 80,3 -32.42% | 9,51 10,7 -10.77% |
Announcement Date | 25/04/19 | 14/05/20 | 27/04/21 | 27/04/22 | 27/04/23 | 25/04/24 |
Quarterly results
Fiscal Period | March | 2020 S1 | 2021 S1 | 2022 S1 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 S1 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 S1 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 S1 | 2025 Q3 | 2025 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million JPY | Released Forecast Spread | 650 470 630 717 3.13% | 615 480 631 150 -2.48% | 651 666 653 900 -0.34% | 340 627 350 400 -2.79% | 303 870 324 327 -6.31% | 381 791 345 350 10.55% | 380 394 360 355 5.56% | 762 185 748 000 1.9% | 402 180 395 900 1.59% | 354 254 361 045 -1.88% | 374 990 357 906 4.77% | 392 148 355 602 10.28% | 767 138 714 088 7.43% | 421 932 385 383 9.48% | 414 602 381 093 8.79% | 411 043 | 426 825 | 800 647 | 454 342 | 392 474 |
EBITDA Million JPY | Released Forecast Spread | 70 087 123 700 -43.34% | 42,0 59 200 -99.93% | 89 100 | 81 600 | 113 400 | 9 300 | ||||||||||||||
EBIT Million JPY | Released Forecast Spread | 162 196 135 036 20.11% | 86 872 139 408 -37.68% | 90 169 138 200 -34.75% | 79 202 73 625 7.57% | -13 685 41 432 -133.03% | 33 147 47 625 -30.4% | 86 744 75 977 14.17% | 119 891 117 500 2.03% | 61 388 83 350 -26.35% | -48 250 26 250 -283.81% | 45 794 67 478 -32.14% | 5 222 53 977 -90.33% | 51 016 94 059 -45.76% | 23 103 47 250 -51.1% | -48 601 18 027 -369.6% | 36 354 | 44 147 | 83 888 | 62 996 | -32 022 |
Earnings before Tax (EBT) Million JPY | Released Forecast Spread | 161 584 134 807 19.86% | 89 091 139 808 -36.28% | 89 085 143 200 -37.79% | 78 317 71 700 9.23% | -10 516 41 300 -125.46% | 31 679 48 800 -35.08% | 88 801 95 700 -7.21% | 120 480 115 500 4.31% | 59 758 78 000 -23.39% | -47 877 27 200 -276.02% | 46 850 66 704 -29.76% | 5 328 52 133 -89.78% | 52 178 93 959 -44.47% | 21 452 54 767 -60.83% | -48 661 -57 900 15.96% | 36 318 | 44 696 | 80 888 | 63 561 | -29 096 |
Net income Million JPY | Released Forecast Spread | 128 527 105 652 21.65% | 72 838 110 808 -34.27% | 71 609 113 700 -37.02% | 60 886 55 900 8.92% | -8 409 32 500 -125.87% | 24 812 35 300 -29.71% | 71 622 74 600 -3.99% | 96 434 90 000 7.15% | 48 405 60 800 -20.39% | -46 125 14 950 -408.53% | 33 129 52 178 -36.51% | -1 459 42 300 -103.45% | 31 670 71 261 -55.56% | 18 653 40 467 -53.91% | -33 278 -44 000 24.37% | 27 999 | 34 678 | 59 857 | 49 383 | -22 479 |
EPS JPY | Released Forecast Spread | 68,2 57,4 18.75% | 39,2 54,5 -28.06% | 38,7 61,4 -37.05% | 32,9 32,1 2.37% | -4,43 15,9 -127.89% | 13,6 18,6 -27.03% | 39,3 33,6 16.89% | 52,9 46,6 13.45% | 26,6 39,2 -32.31% | -25,2 -20,2 -24.61% | 18,5 29,8 -38.06% | -0,80 23,9 -103.35% | 17,7 41,1 -56.98% | 10,4 15,2 -31.36% | -18,6 -8,52 -117.76% | 9,88 | 14,1 | 33,4 | 20,2 | -19,3 |
Announcement Date | 31/10/19 | 30/10/20 | 29/10/21 | 02/02/22 | 27/04/22 | 01/08/22 | 31/10/22 | 31/10/22 | 06/02/23 | 27/04/23 | 01/08/23 | 01/11/23 | 01/11/23 | 05/02/24 | 25/04/24 | - | - | - | - | - |
2024-05-27 | DOTTIKON ES HOLDING AG: Q4 2024 Earnings Release |
2024-05-28 | IPCA LABORATORIES LIMITED: Q4 2024 Earnings Release |
2024-05-28 | FDC LIMITED: Q4 2024 Earnings Release |
2024-05-28 | ALKEM LABORATORIES LIMITED: Q4 2024 Earnings Release |
2024-05-28 | PFIZER LIMITED: Q4 2024 Earnings Release |
2024-05-29 | ASTRAZENECA PHARMA INDIA LIMITED: Q4 2024 Earnings Release |
2024-05-29 | MARKSANS PHARMA LIMITED: Q4 2024 Earnings Release |
2024-05-29 | SUVEN PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release |
2024-05-30 07:00 am | ROIVANT SCIENCES LTD.: Q4 2023 Earnings Release |
2024-05-30 | JUBILANT PHARMOVA LIMITED: Q4 2024 Earnings Release (Projected) |
Past sector events for Astellas Pharma Inc.
Today | CSPC PHARMACEUTICAL GROUP LTD.: Q1 2024 Earnings Release |
Today | NATCO PHARMA LIMITED: Q4 2024 Earnings Release |
2024-05-24 | BLUE JET HEALTHCARE LIMITED: Q4 2024 Earnings Release |
2024-05-24 | AUROBINDO PHARMA: Q4 2024 Earnings Release |
2024-05-24 | DIVI'S LABORATORIES LIMITED: Q4 2024 Earnings Release |
2024-05-24 10:56 am | SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED: Q4 2024 Earnings Release |
2024-05-24 08:18 am | TORRENT PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release |
2024-05-23 10:47 am | ORCHID PHARMA LIMITED: Q4 2024 Earnings Release |
2024-05-23 06:45 am | SHILPA MEDICARE LIMITED: Q4 2024 Earnings Release |
2024-05-22 08:06 am | GLAND PHARMA LIMITED: Q4 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- 4503 Stock
- ALPM.Y Stock
- Calendar Astellas Pharma Inc.